1. Home
  2. BIO vs PARA Comparison

BIO vs PARA Comparison

Compare BIO & PARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • PARA
  • Stock Information
  • Founded
  • BIO 1952
  • PARA 1986
  • Country
  • BIO United States
  • PARA United States
  • Employees
  • BIO N/A
  • PARA N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • PARA Broadcasting
  • Sector
  • BIO Industrials
  • PARA Industrials
  • Exchange
  • BIO Nasdaq
  • PARA Nasdaq
  • Market Cap
  • BIO 6.0B
  • PARA 8.1B
  • IPO Year
  • BIO N/A
  • PARA N/A
  • Fundamental
  • Price
  • BIO $247.92
  • PARA $13.17
  • Analyst Decision
  • BIO Strong Buy
  • PARA Hold
  • Analyst Count
  • BIO 4
  • PARA 14
  • Target Price
  • BIO $324.25
  • PARA $11.50
  • AVG Volume (30 Days)
  • BIO 413.2K
  • PARA 7.9M
  • Earning Date
  • BIO 07-31-2025
  • PARA 08-07-2025
  • Dividend Yield
  • BIO N/A
  • PARA 1.52%
  • EPS Growth
  • BIO N/A
  • PARA N/A
  • EPS
  • BIO N/A
  • PARA N/A
  • Revenue
  • BIO $2,541,100,000.00
  • PARA $28,720,000,000.00
  • Revenue This Year
  • BIO N/A
  • PARA N/A
  • Revenue Next Year
  • BIO $3.49
  • PARA $0.75
  • P/E Ratio
  • BIO N/A
  • PARA N/A
  • Revenue Growth
  • BIO N/A
  • PARA N/A
  • 52 Week Low
  • BIO $211.43
  • PARA $9.95
  • 52 Week High
  • BIO $387.99
  • PARA $13.26
  • Technical
  • Relative Strength Index (RSI)
  • BIO 63.11
  • PARA 74.16
  • Support Level
  • BIO $237.42
  • PARA $12.13
  • Resistance Level
  • BIO $246.50
  • PARA $12.46
  • Average True Range (ATR)
  • BIO 7.71
  • PARA 0.21
  • MACD
  • BIO 2.20
  • PARA 0.07
  • Stochastic Oscillator
  • BIO 78.45
  • PARA 100.00

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About PARA Paramount Global Class B

Paramount Global operates in three global business segments: TV media, filmed entertainment, and direct to consumer. The TV media business includes television production studios and various broadcast and cable networks, including CBS, 15 owned CBS affiliates, Paramount, Nickelodeon, MTV, BET, and VH1. Filmed entertainment consists multiple film studios, most importantly Paramount Pictures. The film studios produce and distribute movies that they license to movie theaters and other media outlets. Direct to consumer includes the Paramount+, Pluto TV, and BET+ streaming services. Much of the content on Paramount's streaming platforms is created by the production studios housed within the firm's other two business segments.

Share on Social Networks: